Phase I Study of HIV Adenoviral Vector Vaccine in Healthy Subjects Using Needle or Biojector Injection
NCT00709605
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
31
Enrollment
NIH
Sponsor class
Conditions
HIV Infections
Interventions
DRUG:
VRC-HIVADV014-00-VP
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)